Osteoarthritis Trial, Recruiting (NCT05547984)

Osteoarthritis Trial, Recruiting NCT05547984 Sponsor: Aesculap AG Condition: Osteoarthritis

Printed from Voxsanity (voxsanity.com.au) — NCT05547984 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Osteoarthritis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with hip joint wear and tear (osteoarthritis) and your doctor has recommended a hip replacement surgery using a type that does not use bone cement
You are willing and able to give written consent to take part in the study

Who may not be able to join:

You have had a serious hip injury or are having a repeat (revision) hip replacement surgery
You have rheumatoid arthritis or a neurological (nerve or brain) condition
Your Body Mass Index (BMI) — a measure of body weight relative to height — is above 35
You are currently receiving treatment for cancer
You have higher than normal levels of certain metals (cobalt or chromium) in your blood before surgery (confirm with trial site)
You already have other joint implants, or it is expected you will need another joint replacement during the study period
The hip socket component needed for your surgery would be smaller than a certain size (confirm with trial site)
You are not able to follow the study requirements or attend the necessary follow-up appointments, either for mental or physical reasons
You are under 18 years old at the time of surgery
You are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +49746195

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05547984

Sponsor: Aesculap AG

Phase: Not Applicable

Status: Recruiting

Condition: Osteoarthritis

Trial contact: +49746195

More information: https://clinicaltrials.gov/study/NCT05547984

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with hip joint wear and tear (osteoarthritis) and your doctor has recommended a hip replacement surgery using a type that does not use bone cement
You are willing and able to give written consent to take part in the study

Who may not be able to join:

You have had a serious hip injury or are having a repeat (revision) hip replacement surgery
You have rheumatoid arthritis or a neurological (nerve or brain) condition
Your Body Mass Index (BMI) — a measure of body weight relative to height — is above 35
You are currently receiving treatment for cancer
You have higher than normal levels of certain metals (cobalt or chromium) in your blood before surgery (confirm with trial site)
You already have other joint implants, or it is expected you will need another joint replacement during the study period
The hip socket component needed for your surgery would be smaller than a certain size (confirm with trial site)
You are not able to follow the study requirements or attend the necessary follow-up appointments, either for mental or physical reasons
You are under 18 years old at the time of surgery
You are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Aesculap AG

Registry

ClinicalTrials.gov

Start date

21 November 2022

Est. completion

1 September 2027

Where this trial is recruiting

🇨🇿 Czechia

Primary endpoints

Serum metal ion analysis (Cobalt); Serum metal ion analysis (Chromium)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov